The Global Cancer Profiling Market size is estimated to grow at a CAGR of around 11.5% during the forecast period, i.e., 2024-30. According to MarkNtel Advisors Study.
Global Cancer Profiling Market Driver:
Rising Adoption of Precision Medicine Augmenting Market Growth – Personalized medicines are treatments that are tailored to a patient’s unique genetic, environmental, and lifestyle characteristics to deliver targeted & precise therapies. The consumers’ growing awareness of personalized medicine’s superior efficacy to conventional medicine for cancer treatment has been driving their demand, especially across countries the US, India, the UK, etc.
Along with the rising awareness, the expanding prevalence of cancer like breast cancer, ovarian cancer, etc., across countries like China, Canada, Australia, etc., due to lifestyle, environmental conditions, genetic mutation, etc., is further creating the need for personalized medicines in these countries. Consequently, the advancement of personalized cancer treatments has spurred the expansion of the cancer profiling services market, as these services are essential during the developmental stages for identifying various biomarkers.
In addition, hospitals, and cancer research centers in recent years have been focussing on providing personalized treatment services to their cancer patients. For instance,
In 2023, the Indian Government and BioNTech SE entered into a memorandum of understanding (MoU), which aims to enhance cancer patients’ access to cutting-edge trials and therapies in development and to extend personalized cancer treatments to more patients.
The increased adoption of personalized cancer treatments, which are tailored to an individual’s unique genetic makeup and specific cancer type, necessitates detailed profiling of the patient’s tumor. Consequently, as the provision of personalized treatment increases across the globe, especially across countries like India, China, the US, etc., it would contribute to an increase in the size of the Global Cancer Profiling Market in the coming years.
Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/cancer-profiling-market.html
Key Market Reports Highlights
- Market Dimensions & Projections
- Pricing Evaluation
- Recent Strategic Moves by Companies
- Primary Stakeholders
- Import/Export Trend Analysis
- Competitive Landscape Assessment
- Emerging Opportunities
- Market Trends and Indicators
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Browse Full Report including(TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/cancer-profiling-market.html
Global Cancer Profiling Market Segmentation:
The market report categorizes the market based on different segments and geographical analysis.
Study Timeline:
-Base Year: 2023
-Historical Period: 2019 to 2022
-Forecast Period: 2024 to 2030
- By Type of Cancer
- Breast Cancer – Market Size & Forecast 2019-2030, USD Million
- Colorectal Cancer – Market Size & Forecast 2019-2030, USD Million
- Gynecological Cancer – Market Size & Forecast 2019-2030, USD Million
- Leukemia – Market Size & Forecast 2019-2030, USD Million
- Prostate Cancer – Market Size & Forecast 2019-2030, USD Million
- Lung Cancer – Market Size & Forecast 2019-2030, USD Million
- Others (Pancreatic Cancer, Skin Cancer, etc.) – Market Size & Forecast 2019-2030, USD Million
- By Technology
- Next-Generation Sequencing – Market Size & Forecast 2019-2030, USD Million
- Polymerase Chain Reaction – Market Size & Forecast 2019-2030, USD Million
- Mass Spectrometry – Market Size & Forecast 2019-2030, USD Million
- In-Situ Hybridization – Market Size & Forecast 2019-2030, USD Million
- Microarrays Analysis – Market Size & Forecast 2019-2030, USD Million
- Others (Single-Cell Sequencing, etc.) – Market Size & Forecast 2019-2030, USD Million
- By Biomarker Type
- Genomic Biomarkers- Market Size & Forecast 2019-2030, USD Million
- Proteomics Biomarkers- Market Size & Forecast 2019-2030, USD Million
- Others (Epigenetic Biomarkers, Metabolomics Biomarkers, etc.)- Market Size & Forecast 2019-2030, USD Million
- By Cell Type
- Germline – Market Size & Forecast 2019-2030, USD Million
- Somatic – Market Size & Forecast 2019-2030, USD Million
- By Application
- Oncology Research – Market Size & Forecast 2019-2030, USD Million
- Precision Medicine – Market Size & Forecast 2019-2030, USD Million
- Clinical Diagnostics – Market Size & Forecast 2019-2030, USD Million
- Others (Prognosis, Monitoring and Recurrence Detection, etc.) – Market Size & Forecast 2019-2030, USD Million
- By End-User
- Hospitals and Clinics – Market Size & Forecast 2019-2030, USD Million
- Research Institutions and Laboratories – Market Size & Forecast 2019-2030, USD Million
- Diagnostic Service Providers – Market Size & Forecast 2019-2030, USD Million
- Pharmaceutical and Biotechnology Companies – Market Size & Forecast 2019-2030, USD Million
- By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia Pacific
Competitive Landscape
With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including – NeoGenomics Laboratories, Eurofins Genomics GmbH, F. Hoffmann-La Roche Ltd (Foundation Medicine) , OncoDNA SA, 10x Genomics, Inc., Caris Life Sciences., Geneseeq Technology Inc., Genetron , Holdings Limited, Laboratory Corporation of America Holdings (LabCorp), Dante Labs Inc., Celemics, Inc., Strand Life Sciences, Myriad Genetics, Inc., QIAGEN GmbH, Tempus Labs, Others are looking forward to strengthening their market positions.
Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/cancer-profiling-market.html
Data-Driven Insights Backed by Proven Research
We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.
From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us
MarkNtel Advisors
Email: sales@marknteladvisors.com
Website: www.marknteladvisors.com
Latest Press Release – https://www.marknteladvisors.com/press-release
